Pacer Advisors
GBT

Pacer Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Pacer Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,772
Closed -$72K – 1596
2021
Q1 		$72K Sell
1,772
-1,478
-45% -$67.9K ﹤0.01% 1364
2020
Q4 		$141K Buy
3,250
+1,574
+94% +$77.6K ﹤0.01% 1293
2020
Q3 		$92K Buy
+1,676
New +$107K ﹤0.01% 1262
2018
Q4 		– Sell
-5,807
Closed -$221K – 1113
2018
Q3 		$221K Buy
+5,807
New +$257K 0.01% 1016
2018
Q1 		– Sell
-1,950
Closed -$77K – 1147
2017
Q4 		$77K Buy
+1,950
New +$72.8K 0.01% 982

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Pacer Advisors's GBT Position: Q2 2021 in Review

Pacer Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2021, closing a stake of 1,772 shares — an estimated $72K sold.

Pacer Advisors first reported a position in GBT in Q4 2017 and held it in 5 quarters. The position peaked at $221K in Q3 2018. 191 funds tracked by Wall St. Rank hold GBT as of Q2 2021.

  • Pacer Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 1,772 Global Blood Therapeutics, Inc. shares in Q2 2021, an estimated $72K.
  • Pacer Advisors first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 5 quarters.
  • Pacer Advisors's Global Blood Therapeutics, Inc. position peaked at $221K in Q3 2018.
  • 191 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.